Goldman Sachs
PLSE icon

Goldman Sachs’s Pulse Biosciences PLSE Stock Holding History

Goldman Sachs’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$953K Buy
34,379
+5,668
+20% +$134K ﹤0.01% 5253
2026
Q1 		$620K Buy
28,711
+6,258
+28% +$116K ﹤0.01% 5461
2025
Q4 		$308K Buy
22,453
+5,322
+31% +$82.9K ﹤0.01% 5853
2025
Q3 		$303K Buy
17,131
+5,546
+48% +$87.7K ﹤0.01% 5747
2025
Q2 		$175K Sell
11,585
-27,462
-70% -$456K ﹤0.01% 5698
2025
Q1 		$628K Sell
39,047
-11,208
-22% -$209K ﹤0.01% 5045
2024
Q4 		$875K Buy
50,255
+14,560
+41% +$257K ﹤0.01% 4906
2024
Q3 		$626K Buy
+35,695
New +$609K ﹤0.01% 4925
2024
Q2 		– Sell
-12,206
Closed -$106K – 5863
2024
Q1 		$106K Buy
+12,206
New +$112K ﹤0.01% 5240
2023
Q3 		– Sell
-10,279
Closed -$73.9K – 5785
2023
Q2 		$73.9K Buy
+10,279
New +$65.7K ﹤0.01% 5408
2022
Q3 		– Sell
-12,173
Closed -$19K – 6470
2022
Q2 		$19K Sell
12,173
-3,622
-23% -$9.11K ﹤0.01% 6183
2022
Q1 		$77K Buy
15,795
+3,273
+26% +$26.8K ﹤0.01% 6180
2021
Q4 		$185K Buy
12,522
+66
+0.5% +$1.31K ﹤0.01% 5935
2021
Q3 		$269K Buy
12,456
+1,244
+11% +$26.8K ﹤0.01% 5569
2021
Q2 		$184K Sell
11,212
-10,409
-48% -$198K ﹤0.01% 5767
2021
Q1 		$512K Buy
21,621
+12,664
+141% +$379K ﹤0.01% 5102
2020
Q4 		$214K Buy
+8,957
New +$142K ﹤0.01% 5056
2017
Q4 		– Sell
-20,761
Closed -$386K – 6576
2017
Q3 		$386K Buy
20,761
+2,646
+15% +$60.1K ﹤0.01% 5288
2017
Q2 		$626K Sell
18,115
-4,868
-21% -$134K ﹤0.01% 4891
2017
Q1 		$469K Sell
22,983
-19,898
-46% -$271K ﹤0.01% 5094
2016
Q4 		$279K Sell
42,881
-9,187
-18% -$54.4K ﹤0.01% 5542
2016
Q3 		$328K Buy
52,068
+27,068
+108% +$138K ﹤0.01% 5410
2016
Q2 		$112K Buy
+25,000
New +$108K ﹤0.01% 6071

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Goldman Sachs's PLSE Position: Q2 2026 in Review

Goldman Sachs increased its Pulse Biosciences (PLSE) stake by 20% in Q2 2026, buying an estimated $134K and bringing the position to 34,379 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #5253.

Goldman Sachs first reported a position in PLSE in Q2 2016 and has held it in 23 quarters since. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Goldman Sachs held 34,379 shares of Pulse Biosciences worth $953K as of Q2 2026.
  • Goldman Sachs bought 5,668 Pulse Biosciences shares in Q2 2026, an estimated $134K.
  • Pulse Biosciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5253 holding.
  • Goldman Sachs first reported a position in Pulse Biosciences in Q2 2016 and has held it in 23 quarters since.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.